France withdraws two Bayer HIV tests:
This article was originally published in Clinica
The French Healthcare Products Safety Agency, AFSSAPS, has withdrawn two of Bayer's HIV tests from the market. The decision is based on the grounds that the sensitivity results of the assays - Serodia HIV and Serodia HIV 1/2 - were borderline and that it would be impossible to improve their performance. The tests are manufactured by Japan's Fujirebio and marketed in France by Bayer. The German company is not aware of the same products being banned in other countries in Europe. France banned six other HIV tests in June.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.